DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vepesid (Etoposide) - White Blood Cell Count Decreased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with White Blood Cell Count Decreased (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vepesid (Etoposide) where reactions include white blood cell count decreased. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vepesid side effects in 19 year old female

Reported by a consumer/non-health professional from United States on 2012-08-20

Patient: 19 year old female, weighing 44.0 kg (96.8 pounds)

Reactions: White Blood Cell Count Decreased

Drug(s) suspected as cause:
Ipilimumab
    Dosage: cyc 1-4(21 days), cyc 5+ (12wks) 10 mg/kg over 90 min day1. courses:1. last admin: 10aug11
    Indication: Bone Sarcoma
    Start date: 2011-08-10

Vepesid

Ifosfamide



Possible Vepesid side effects in 19 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20

Patient: 19 year old female, weighing 44.0 kg (96.8 pounds)

Reactions: White Blood Cell Count Decreased, Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Vepesid

Ifosfamide

Ipilimumab
    Dosage: 10mg/kg iv over 90 min on day 1 last dose on 18oct2011; 470 mg
    Indication: Bone Sarcoma
    Start date: 2011-08-10



Possible Vepesid side effects in 19 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-16

Patient: 19 year old female, weighing 44.0 kg (96.8 pounds)

Reactions: White Blood Cell Count Decreased

Drug(s) suspected as cause:
Ipilimumab
    Dosage: cyc 1-4(21 days), cyc 5+ (12wks) 10 mg/kg over 90 min day1. courses:1. last admin: 10aug11
    Indication: Bone Sarcoma
    Start date: 2011-08-10

Ifosfamide

Vepesid



Possible Vepesid side effects in 54 year old female

Reported by a physician from Taiwan, Province of China on 2012-04-05

Patient: 54 year old female, weighing 58.4 kg (128.5 pounds)

Reactions: White Blood Cell Count Decreased, Febrile Neutropenia, non-Hodgkin's Lymphoma Recurrent

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytosar-U
    Dosage: 3000 mg, 1x/day
    Start date: 2012-03-07
    End date: 2012-03-07

Vepesid
    Dosage: 65 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03
    End date: 2012-03-07

Inotuzumab Ozogamicin
    Dosage: 2.77 mg, cyclic, day 2 of each 28 day cycle
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-01-06
    End date: 2012-02-03

Rituximab
    Dosage: 577.5 mg, cyclic, day 1 of each 28 day cycle
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-01-05
    End date: 2012-02-02

Solu-Medrol
    Dosage: 500 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03
    End date: 2012-03-07

Abiplatin
    Dosage: 40 mg, 1x/day
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-03-03
    End date: 2012-03-06

Other drugs received by patient: Ultracet; Vitamin B6; Chlorhexidine; Norvasc; Senokot; Aloxi

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017